raloxifene hydrochloride has been researched along with Bone Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agotegaray, M; Azcona, P; Campelo, A; Lassalle, V; Massheimer, V; Montiel Schneider, MG | 1 |
| Allen, MR; Berman, A; Powell, KM; Pulliam, A; Skaggs, C; Wallace, JM | 1 |
| Anwar, MJ; Radhakrishna, KV; Sharma, A; Vohora, D | 1 |
| Ambroggio, S; Biglia, N; Cozzarella, M; Ponzone, R; Roagna, R; Sgro, L; Sismondi, P | 1 |
4 other study(ies) available for raloxifene hydrochloride and Bone Diseases
| Article | Year |
|---|---|
Magnetic Nanoplatform With Novel Potential for the Treatment of Bone Pathologies: Drug Loading and Biocompatibility on Blood and Bone Cells.
Topics: Bone Diseases; Citric Acid; Drug Delivery Systems; Endothelial Cells; Humans; Magnetic Phenomena; Magnetite Nanoparticles; Raloxifene Hydrochloride | 2023 |
Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone.
Topics: Animals; Biomechanical Phenomena; Bone Diseases; Calcification, Physiologic; Cancellous Bone; Diaphyses; Drug Therapy, Combination; Femur; Fractures, Bone; Male; Mice, Inbred C57BL; Raloxifene Hydrochloride; Zoledronic Acid | 2019 |
Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-β3 content in bone of female mice.
Topics: Animals; Anticonvulsants; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases; Estradiol; Female; Mice; Phenytoin; Raloxifene Hydrochloride; Seizures; Selective Estrogen Receptor Modulators; Transforming Growth Factor beta3; Valproic Acid | 2014 |
How to manage the menopause following therapy for breast cancer. is raloxifene a safe alternative?
Topics: Blood Coagulation Disorders; Bone Diseases; Breast Neoplasms; Female; Humans; Lipids; Menopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uterine Diseases | 2000 |